462 related articles for article (PubMed ID: 19591199)
1. Enhanced number and activity of mitochondria in multiple sclerosis lesions.
Witte ME; Bø L; Rodenburg RJ; Belien JA; Musters R; Hazes T; Wintjes LT; Smeitink JA; Geurts JJ; De Vries HE; van der Valk P; van Horssen J
J Pathol; 2009 Oct; 219(2):193-204. PubMed ID: 19591199
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of osteopontin and alphaBeta-crystallin in the normal-appearing white matter of multiple sclerosis: an immunohistochemical study utilizing tissue microarrays.
Sinclair C; Mirakhur M; Kirk J; Farrell M; McQuaid S
Neuropathol Appl Neurobiol; 2005 Jun; 31(3):292-303. PubMed ID: 15885066
[TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis: a protective or a pathogenic role for heat shock protein 60 in the central nervous system?
Raine CS; Wu E; Ivanyi J; Katz D; Brosnan CF
Lab Invest; 1996 Jul; 75(1):109-23. PubMed ID: 8683935
[TBL] [Abstract][Full Text] [Related]
4. Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis.
Wolswijk G; Balesar R
Brain; 2003 Jul; 126(Pt 7):1638-49. PubMed ID: 12805111
[TBL] [Abstract][Full Text] [Related]
5. Peroxiredoxin V in multiple sclerosis lesions: predominant expression by astrocytes.
Holley JE; Newcombe J; Winyard PG; Gutowski NJ
Mult Scler; 2007 Sep; 13(8):955-61. PubMed ID: 17623739
[TBL] [Abstract][Full Text] [Related]
6. Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis.
Geurts JJ; Wolswijk G; Bö L; van der Valk P; Polman CH; Troost D; Aronica E
Brain; 2003 Aug; 126(Pt 8):1755-66. PubMed ID: 12805104
[TBL] [Abstract][Full Text] [Related]
7. Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis.
Leech S; Kirk J; Plumb J; McQuaid S
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):86-98. PubMed ID: 17239011
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.
Koning N; Bö L; Hoek RM; Huitinga I
Ann Neurol; 2007 Nov; 62(5):504-14. PubMed ID: 17879969
[TBL] [Abstract][Full Text] [Related]
9. Amyloid precursor protein (APP) expression in multiple sclerosis lesions.
Gehrmann J; Banati RB; Cuzner ML; Kreutzberg GW; Newcombe J
Glia; 1995 Oct; 15(2):141-51. PubMed ID: 8567065
[TBL] [Abstract][Full Text] [Related]
10. Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions.
Nijland PG; Michailidou I; Witte ME; Mizee MR; van der Pol SM; van Het Hof B; Reijerkerk A; Pellerin L; van der Valk P; de Vries HE; van Horssen J
Glia; 2014 Jul; 62(7):1125-41. PubMed ID: 24692237
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of distinct galectins in multiple sclerosis lesions.
Stancic M; van Horssen J; Thijssen VL; Gabius HJ; van der Valk P; Hoekstra D; Baron W
Neuropathol Appl Neurobiol; 2011 Oct; 37(6):654-71. PubMed ID: 21501208
[TBL] [Abstract][Full Text] [Related]
12. Gene expression analysis of the microvascular compartment in multiple sclerosis using laser microdissected blood vessels.
Cunnea P; McMahon J; O'Connell E; Mashayekhi K; Fitzgerald U; McQuaid S
Acta Neuropathol; 2010 May; 119(5):601-15. PubMed ID: 19967542
[TBL] [Abstract][Full Text] [Related]
13. [The evidence for primary axonal loss in multiple sclerosis].
Anthony DC; Hughes P; Perry VH
Rev Neurol; 2000 Jun 16-30; 30(12):1203-8. PubMed ID: 10935251
[TBL] [Abstract][Full Text] [Related]
14. Elevated protein carbonylation in the brain white matter and gray matter of patients with multiple sclerosis.
Bizzozero OA; DeJesus G; Callahan K; Pastuszyn A
J Neurosci Res; 2005 Sep; 81(5):687-95. PubMed ID: 16007681
[TBL] [Abstract][Full Text] [Related]
15. The blood-brain barrier in cortical multiple sclerosis lesions.
van Horssen J; Brink BP; de Vries HE; van der Valk P; Bø L
J Neuropathol Exp Neurol; 2007 Apr; 66(4):321-8. PubMed ID: 17413323
[TBL] [Abstract][Full Text] [Related]
16. Differences in expression of junctional adhesion molecule-A and beta-catenin in multiple sclerosis brain tissue: increasing evidence for the role of tight junction pathology.
Padden M; Leech S; Craig B; Kirk J; Brankin B; McQuaid S
Acta Neuropathol; 2007 Feb; 113(2):177-86. PubMed ID: 17024496
[TBL] [Abstract][Full Text] [Related]
17. Axonal transection in the lesions of multiple sclerosis.
Trapp BD; Peterson J; Ransohoff RM; Rudick R; Mörk S; Bö L
N Engl J Med; 1998 Jan; 338(5):278-85. PubMed ID: 9445407
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions.
van Horssen J; Drexhage JA; Flor T; Gerritsen W; van der Valk P; de Vries HE
Free Radic Biol Med; 2010 Nov; 49(8):1283-9. PubMed ID: 20673799
[TBL] [Abstract][Full Text] [Related]
19. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
[TBL] [Abstract][Full Text] [Related]
20. Identification and investigation of mitochondria lacking cytochrome c oxidase activity in axons.
Zambonin J; Engeham S; Campbell GR; Ziabreva I; Beadle NE; Taylor RW; Mahad DJ
J Neurosci Methods; 2010 Sep; 192(1):115-20. PubMed ID: 20659500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
